Viking Therapeutics VKTX
NASDAQ VKTX
$25.81 -0.57 (-2.18%)
As of: Oct 22, 2026 · 3:58 PM EDT

Viking Therapeutics (VKTX) Long-Term Debt Issuances (2014)

Updated

Viking Therapeutics (VKTX) recorded Long-Term Debt Issuances of $500,000 in Q4 2014, down 33.3% from the prior quarter.

Analysis

Viking Therapeutics (VKTX) Long-Term Debt Issuances (2014) Analysis & Trends

For FY2014, Viking Therapeutics reported Long-Term Debt Issuances of $2.5 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Viking Therapeutics 2.99 Bn 464.96 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 500,000.00
Sep 30, 2014 750,000.00
API Access

Viking Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=VKTX&period=max&api_key=YOUR_API_KEY